Charleston Neuroscience Institute - Beaufort — Beaufort, South Carolina

Charleston Neuroscience Institute - Beaufort is a clinical research site located in Beaufort, South Carolina, United States 29902.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Charleston Neuroscience Institute - Beaufort has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Neovascular Age-Related Macular Degeneration, Diabetic Macular Edema, DME.

Sponsors: Ocular Therapeutix, Inc., EyePoint Pharmaceuticals, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Beaufort

Browse all research sites in South Carolina · View every site in Beaufort

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Charleston Neuroscience Institute - Beaufort?

Charleston Neuroscience Institute - Beaufort has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Charleston Neuroscience Institute - Beaufort conducted?

Charleston Neuroscience Institute - Beaufort has 2 clinical trials on record, with 2 currently active. Their work covers Neovascular Age-Related Macular Degeneration, Diabetic Macular Edema, DME.

Is Charleston Neuroscience Institute - Beaufort accredited by Crixeo Clinical Trials?

Charleston Neuroscience Institute - Beaufort has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Charleston Neuroscience Institute - Beaufort?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.